RecruitingNCT06884839
Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis
Sponsor
Minia University
Enrollment
30 participants
Start Date
Aug 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to evaluate the tumor deposits in colorectal cancer and its prognostic value in survival and metastasis
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age above 18 years old.
- Both sexes.
- All Colorectal cancer patients From Stage I to III Colorectal cancer with pathologically positive Tumor deposits.
Exclusion Criteria4
- Patient took neoadjuvant therapy.
- No information available on tumor deposits.
- Colorectal cancer is not the only primary cancer.
- Patients with incomplete information about follow-up.
Interventions
PROCEDURETherapeutic resection
Patients with colorectal cancer underwent therapeutic resection with pathologically positive tumor deposits (TDs) to determine distant metastasis occurrence and the effect of TDs on survival.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06884839
Related Trials
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
NCT0546403035 locations
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
NCT065632451 location
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
NCT070717141 location
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)
NCT0701157614 locations
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
NCT069922589 locations